Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

CAMBRIDGE (dpa-AFX) - Nur wenige Tage nach den richtungsweisenden US-Präsidentschaftswahlen hat der britisch-schwedische Pharmakonzern Astrazeneca dort milliardenschwere Investitionen angekündigt.…

AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat…

12 November 2024 AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States AstraZeneca today announces $3.5 billion of capital investment…

AstraZeneca 12 November 2024 9M and Q3 2024 results Upgrade to full year 2024 guidance underpinned by strong underlying growth momentum Revenue and EPS…

12 November 2024 Datopotamab deruxtecan new BLA submitted for accelerated approval in the US for patients with previously treated advanced EGFR-mutated non-small…

AZN beats third-quarter estimates for earnings and sales. It raises its sales and profit outlook for 2024 for the second…

AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday…

…

Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe…

Toronto (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von BMO Capital Markets: 1. Überblick über die Situation AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London…